(Q53429971)

English

The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.

scientific article published on 18 December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jacek Roliński

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Krzysztof Giannopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sylwia Chocholska

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jacek Roliński

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

A Bühler

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

T F E Barth

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

I Idler

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P Möller

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Kröber

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J Greiner

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Dmoszyñska

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

H Döhner

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Stilgenbauer

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Schmitt

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

18 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

519-527

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19092852%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

https://scigraph.springernature.com/pub.10.1038/leu.2008.338

0 references

Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

21 January 2018

Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

21 January 2018

Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

21 January 2018

Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

21 January 2018

RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

21 January 2018

Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

21 January 2018

Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

21 January 2018

RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

21 January 2018

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

21 January 2018

New prognostic markers in CLL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

7 January 2021

based on heuristic

inferred from DOI database lookup

Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of methods for determining zeta-chain associated protein - 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki67 staining pattern as a diagnostic tool in the evaluation of lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

7 January 2021

based on heuristic

inferred from DOI database lookup

The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolving view of the in-vivo kinetics of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.338

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53429971&oldid=2124151526"